Traitement par immunoglobulines intraveineuses (IgIV) de la sclerose en plaques

Translated title of the contribution: Intravenous immunoglobulins (IVIg) in the treatment of multiple sclerosis

Anat Achiron, Shmuel Miron

Research output: Contribution to journalReview articlepeer-review


Intravenously administered immunoglobulins (IVIg) have been used for the treatment of various autoimmune diseases. In multiple sclerosis (MS), recent studies point out the beneficial role of this treatment that reduces relapse rate and arrests disease progression in relapsing-remitting patients. In the present article, we summarize and interpret the clinical, immunological, and neuro-radiological data related to IVIg treatment in MS. A synthesis between the information gathered will enable better understanding and treatment of this chronic disease.

Translated title of the contributionIntravenous immunoglobulins (IVIg) in the treatment of multiple sclerosis
Original languageFrench
Pages (from-to)1S41-1S44
JournalAnnales de Medecine Interne
Issue numberSUPPL. 1
StatePublished - 2000
Externally publishedYes


  • Intravenous immunoglobulins
  • IVIg
  • Multiple sclerosis


Dive into the research topics of 'Intravenous immunoglobulins (IVIg) in the treatment of multiple sclerosis'. Together they form a unique fingerprint.

Cite this